Rheumatology Network

Complete Coverage at ACR2014

Must you regretfully miss the event of the year, the American College of Rheumatology annual meeting? Or are you planning to dive into the maelstrom of events at ACR2014? Either way, Rheumatology Network will be there to alert you to the latest and best from the conference. New this year: On-the-spot commentary from Washington DC rheumatologist Paul DeMarco MD.

Recent Content

(ACR2014) In this video interview, Genentech's Vice President for Immunology and Infectious Diseases gives the company's latest information about safe uses of the classic biologic.

MRI proves itself as a valuable tool for pinpointing inflammatory and structural damage in select rheumatoid arthritis patients.

New data boosts confidence in drug therapies for osteoporosis, but more research in older adults is required.

A new scoring system for knee ultrasound is proposed for improving diagnosis of the condition.

Rheumatologists (and others) have a long-awaited roadmap to guide them in treating non-radiographic axial spondyloarthritis and ankylosing spondylitis, with important landmarks to help manage active and stable disease.

(ACR2014) Hot news at last year's American College of Rheumatology annual meeting, the newly approved psoriatic arthritis drug apremilast has proven safe and effective in longer-term studies.

(ACR2014) In a large prospective study, rheumatoid arthritis patients younger and healthier at baseline were more likely to achieve six-month remission. Choice of drug regimen was also an important factor.

By clicking Accept, you agree to become a member of the UBM Medica Community.